Microneedling and keloids: a scar history is different from a scar target
FDA flags keloids and keloid history as suitability issues. A device authorized for facial acne scars and a small study of raised scars answer different questions.
A history of keloids changes a microneedling consultation even if the proposed area has no raised scar. FDA lists keloids and a history of them among circumstances that can affect suitability. The original SkinPen facial acne-scar study excluded people with current or prior keloid or hypertrophic scars. That evidence leaves a gap for a person with this history.12
Two questions can sound like the same booking request
“I have a keloid” might mean there is a raised scar the person wants treated, or that a past injury caused a raised scar somewhere else. The first question is about the scar itself. The second is about response to a procedure at a different site. Both belong in the record, and the original indication for facial acne scars does not settle either one.12
A keloid can extend beyond the original wound. The appearance and history of a raised scar are clinical observations. If someone was told their scar was hypertrophic, or has never had it assessed, keep that distinction in the history rather than applying a label from a photo. The guide to acne scar types explains why a depressed scar and a raised scar do not share one treatment goal.4
Separate a device indication from a study exclusion
The FDA De Novo record for the SkinPen Precision System gives a specific indication for facial acne scars in adults 22 and older. Its review also describes who was excluded from the supporting study. An exclusion limits the people to whom the results can confidently be applied. It is not the same as an FDA claim that every person outside that sample will have a complication. The proposed device’s own labeling and the patient’s clinical history still need review.12
One small original study investigated medical needling and silicone gel in existing raised scars. It included 20 people with keloids or hypertrophic scars and compared treatments on halves of scars. Its pooled findings do not provide a separate estimate for people with keloids. They also do not address the risk of creating a new raised scar at an unrelated site after a cosmetic appointment.3
| Starting question | What it calls for |
|---|---|
| Existing scar | Identify the scar and the outcome under discussion before evaluating the proposed treatment. |
| Scar history | Share the original injury, site, healing history and any clinician diagnosis. |
| Facial acne scars | Ask whether the exact device and the scar type match the relevant FDA record. |
What counts as relevant research for the proposed area?
Suppose a provider points to a study of a device for depressed facial acne scars. That study can establish how the device performed for the scar pattern and population it evaluated. A study that worked on already-formed raised scars starts from a different condition and aims to change the existing scar. Neither population tells the provider how skin at a separate, unscarred area will respond in a person who previously formed a keloid. A consultation that records both the proposed site and the site of the previous scar makes this evidence gap visible.23
Leave the consultation with a defined goal
When comparing microneedling providers, ask who reviews scar history before a device is selected and whether the practice can name the device, intended site and evidence relevant to the scar. Prior dark marks after a procedure are another useful part of the record, covered in the pigment-risk guide. Pigment change and raised scarring call for different assessments.
Sources
- U.S. Food and Drug Administration. Microneedling Devices. Includes existing or prior keloids among factors relevant to suitability. Accessed .
- U.S. Food and Drug Administration. De Novo Classification Request for SkinPen Precision System, DEN160029. Documents the facial acne-scar indication and the exclusion of current or prior hypertrophic or keloid scars in the supporting study. Accessed .
- PubMed / original research. Assessment of the Combined Efficacy of Needling and the Use of Silicone Gel in the Treatment of C-Section and Other Surgical Hypertrophic Scars and Keloids. Original small split-scar study combines two scar types and does not establish a separate keloid-specific benefit. Accessed .
- American Academy of Dermatology. Keloid scars: Overview. Defines keloids and explains extension beyond the original wound. Accessed .